Medical School · Year 3 · Internal Medicine · includes a discussion video

Seminar 14: Acid-Base Disorders

Internal Medicine Clerkship

Learning Objectives

By the end of this seminar, students will be able to:

1. Interpret arterial blood gas results systematically using a stepwise approach to identify primary disorders and assess compensation
2. Differentiate the four primary acid-base disorders based on pH, PaCO2, and bicarbonate values
3. Calculate the anion gap and apply the delta-delta ratio to identify mixed acid-base disturbances
4. Identify the common causes of anion gap and non-anion gap metabolic acidosis using established mnemonics and clinical reasoning
5. Describe the etiologies, classification, and management of metabolic alkalosis and respiratory acid-base disorders
6. Recognize mixed acid-base disturbances through systematic analysis and apply this knowledge to common clinical scenarios

Seminar Outline

Section 1: Acid-Base Physiology

The normal physiology of acid-base balance maintains the arterial blood pH within a remarkably narrow range of 7.35 to 7.45, which is essential for optimal enzyme function, cellular metabolism, and organ system performance. The arterial partial pressure of carbon dioxide normally ranges from 35 to 45 millimeters of mercury and represents the respiratory component of acid-base balance, regulated by alveolar ventilation. The serum bicarbonate concentration normally ranges from 22 to 26 milliequivalents per liter and represents the metabolic component, regulated by renal bicarbonate reabsorption and regeneration. The arterial partial pressure of oxygen normally ranges from 80 to 100 millimeters of mercury and, while not directly part of the acid-base system, provides critical information about oxygenation status that may illuminate the underlying cause of an acid-base disturbance.

The Henderson-Hasselbalch equation provides the mathematical framework for understanding the relationship between pH, bicarbonate, and carbon dioxide. The equation states that pH equals 6.1 plus the logarithm of the ratio of bicarbonate concentration to 0.03 times the PaCO2. In simplified clinical terms, the pH reflects the ratio of bicarbonate (the metabolic component, controlled by the kidneys) to carbon dioxide (the respiratory component, controlled by the lungs), and any change in one component will alter the pH unless the other component compensates. Acidemia is defined as a blood pH below 7.35 and indicates that the net effect of all acid-base processes has shifted the balance toward acidity. Alkalemia is defined as a blood pH above 7.45 and indicates a net shift toward alkalinity. Importantly, the terms acidosis and alkalosis refer to the pathological processes that tend to lower or raise the pH, respectively, and a patient may have one or more concurrent acid-base processes.

The body employs three lines of defense against changes in pH, operating at different time scales. The bicarbonate buffer system is the most important extracellular buffer and operates immediately through the equilibrium between carbon dioxide, carbonic acid, and bicarbonate. Hemoglobin is the most important intracellular buffer and acts within minutes to buffer changes in pH by binding hydrogen ions. Phosphate and protein buffers play minor but contributory roles. These chemical buffers provide immediate defense but have limited capacity, and sustained acid-base disturbances require physiological compensation by the lungs and kidneys. The lungs can rapidly alter carbon dioxide excretion through changes in alveolar ventilation (respiratory compensation), while the kidneys provide more sustained correction through changes in bicarbonate reabsorption, generation, and hydrogen ion excretion (metabolic compensation).

Physiological compensation is a predictable response to primary acid-base disturbances and follows well-defined quantitative relationships. In metabolic acidosis, the respiratory system compensates by increasing alveolar ventilation to lower PaCO2, reducing the acid load. In metabolic alkalosis, the respiratory system compensates by decreasing ventilation to raise PaCO2, partially restoring the bicarbonate-to-CO2 ratio. In respiratory acidosis, the kidneys compensate by increasing bicarbonate reabsorption and generation, with the magnitude of compensation differing between acute and chronic disturbances. In respiratory alkalosis, the kidneys compensate by decreasing bicarbonate reabsorption and increasing bicarbonate excretion. A critical principle is that physiological compensation is always partial and never fully normalizes the pH back to 7.40. If the pH is completely normal in the presence of abnormal bicarbonate and PaCO2 values, two opposing primary processes (a mixed disorder) should be suspected.

<image>Panel A: Normal acid-base values display showing pH (7.35-7.45), PaCO2 (35-45 mmHg), HCO3 (22-26 mEq/L), and PaO2 (80-100 mmHg) on an arterial blood gas result printout with labeled normal ranges highlighted. Panel B: Henderson-Hasselbalch equation diagram showing pH as a balance scale with bicarbonate (metabolic/kidney-regulated) on one side and PaCO2 (respiratory/lung-regulated) on the other, with the 6.1 constant and logarithmic relationship annotated. Panel C: Buffer system hierarchy showing three levels: immediate chemical buffers (bicarbonate, hemoglobin, phosphate, proteins), rapid respiratory compensation (minutes to hours, ventilation changes), and sustained renal compensation (hours to days, bicarbonate handling), with time course arrows. Panel D: Four compensation diagrams showing the predictable response to each primary disorder: metabolic acidosis (respiratory compensation lowers CO2), metabolic alkalosis (respiratory compensation raises CO2), respiratory acidosis (renal compensation raises HCO3), and respiratory alkalosis (renal compensation lowers HCO3), with the principle that compensation never fully normalizes pH.</image>

Section 2: Systematic ABG Interpretation

The systematic interpretation of an arterial blood gas begins with Step 1: assessment of the pH to determine whether the patient is acidemic or alkalemic. A pH below 7.35 indicates acidemia, meaning that the dominant process has shifted the blood pH toward acidity. A pH above 7.45 indicates alkalemia, meaning that the dominant process has shifted the blood toward alkalinity. A pH within the normal range of 7.35 to 7.45 may indicate either a normal acid-base status or a fully compensated or mixed disorder in which opposing processes have produced a near-normal pH. When the pH is normal but the bicarbonate or PaCO2 is abnormal, the clinician should consider the possibility that two or more acid-base processes are present simultaneously, with their effects on pH canceling each other.

Step 2 involves identifying the primary disorder by examining the PaCO2 and bicarbonate in the context of the pH. A low pH combined with a low bicarbonate identifies a primary metabolic acidosis, in which the loss of bicarbonate or accumulation of acid has overwhelmed the buffering capacity. A low pH combined with a high PaCO2 identifies a primary respiratory acidosis, in which inadequate ventilation has led to carbon dioxide retention. A high pH combined with a high bicarbonate identifies a primary metabolic alkalosis, in which excess bicarbonate or loss of acid has shifted the balance toward alkalinity. A high pH combined with a low PaCO2 identifies a primary respiratory alkalosis, in which hyperventilation has produced excessive carbon dioxide elimination. The primary disorder is always the one that is consistent with the direction of the pH change.

Step 3 requires assessing whether the degree of compensation is appropriate for the primary disorder using established compensation formulas. For metabolic acidosis, the expected PaCO2 is calculated using Winter's formula: PaCO2 equals 1.5 times the bicarbonate plus 8, with a range of plus or minus 2. For metabolic alkalosis, the expected PaCO2 equals 0.7 times the bicarbonate plus 21, with a range of plus or minus 2. For acute respiratory acidosis, the bicarbonate increases by 1 milliequivalent per liter for every 10 millimeters of mercury increase in PaCO2. For chronic respiratory acidosis, the bicarbonate increases by 3.5 milliequivalents per liter for every 10 millimeters of mercury increase. For acute respiratory alkalosis, the bicarbonate decreases by 2 milliequivalents per liter for every 10 millimeters of mercury decrease in PaCO2. For chronic respiratory alkalosis, the bicarbonate decreases by 5 milliequivalents per liter for every 10 millimeters of mercury decrease. If the actual compensation differs from the expected values, a mixed disorder is present.

Step 4 applies specifically to metabolic acidosis and involves calculating the anion gap to determine whether unmeasured anions are contributing to the acidosis. The anion gap is calculated as serum sodium minus the sum of serum chloride and bicarbonate, and the normal value is 8 to 12 milliequivalents per liter, although this varies by laboratory and should be corrected for albumin. An elevated anion gap above 12 to 14 milliequivalents per liter indicates the presence of unmeasured anions in the blood, such as lactate, ketoacids, or toxic metabolites. The delta-delta ratio, calculated as the change in anion gap divided by the change in bicarbonate, is a powerful tool for identifying mixed disorders superimposed on an anion gap metabolic acidosis. A delta-delta ratio between 1 and 2 indicates a pure anion gap metabolic acidosis, a ratio less than 1 suggests a concurrent non-anion gap metabolic acidosis (the bicarbonate has fallen more than expected from the unmeasured anion alone), and a ratio greater than 2 suggests a concurrent metabolic alkalosis (the bicarbonate has not fallen as much as expected).

<image>Panel A: Step 1 pH assessment displayed as a horizontal pH scale from 6.8 to 7.8 with acidemia zone (below 7.35) highlighted in red, normal zone (7.35-7.45) in green, and alkalemia zone (above 7.45) in blue, with clinical implications annotated at each zone. Panel B: Step 2 primary disorder identification matrix showing four quadrants: low pH with low HCO3 (metabolic acidosis), low pH with high CO2 (respiratory acidosis), high pH with high HCO3 (metabolic alkalosis), and high pH with low CO2 (respiratory alkalosis), with directional arrows. Panel C: Step 3 compensation assessment showing six formulas in a reference card format: Winter's formula for metabolic acidosis, metabolic alkalosis compensation formula, and acute and chronic compensation formulas for both respiratory acidosis and alkalosis, with expected ranges and "if different, suspect mixed disorder" annotation. Panel D: Step 4 anion gap calculation showing the formula Na minus (Cl plus HCO3) with normal range 8-12, albumin correction formula, and the delta-delta ratio interpretation ladder: less than 1 (concurrent NAGMA), 1-2 (pure AGMA), greater than 2 (concurrent metabolic alkalosis).</image>

Section 3: Anion Gap Metabolic Acidosis

The anion gap metabolic acidosis is characterized by the accumulation of unmeasured anions in the blood, which displace bicarbonate and produce acidosis while widening the anion gap. The MUDPILES mnemonic provides a systematic framework for remembering the major causes: Methanol ingestion produces formic acid; Uremia from renal failure leads to accumulation of sulfate, phosphate, and other organic acids; Diabetic ketoacidosis produces beta-hydroxybutyrate and acetoacetate; Propylene glycol, used as a solvent in intravenous medications, is metabolized to lactic acid; Isoniazid and Iron toxicity both cause lactic acidosis through different mechanisms; Lactic acidosis from tissue hypoperfusion or impaired metabolism; Ethylene glycol produces glycolic and oxalic acids; and Salicylate toxicity produces both a direct metabolic acidosis and a respiratory alkalosis. This comprehensive mnemonic covers the vast majority of clinically significant anion gap metabolic acidoses encountered in practice.

Lactic acidosis is the most common cause of anion gap metabolic acidosis encountered in clinical practice and is classified into two types based on mechanism. Type A lactic acidosis results from tissue hypoxia due to inadequate oxygen delivery and is caused by conditions including sepsis, hypovolemic shock, cardiogenic shock, severe anemia, and carbon monoxide poisoning, all of which impair tissue oxygenation and force anaerobic glycolysis with lactate production. Type B lactic acidosis occurs without global tissue hypoxia and is caused by medications (metformin being the most commonly implicated, particularly in the setting of renal failure that impairs metformin clearance), malignancy (particularly hematologic malignancies with high cell turnover), liver failure (which impairs lactate clearance), and seizures (which produce massive muscle lactate generation). Common clinical scenarios include sepsis, which combines both type A (from distributive shock) and type B (from mitochondrial dysfunction) mechanisms, and metformin-associated lactic acidosis in patients who develop acute kidney injury.

Diabetic ketoacidosis is a common and clinically important cause of anion gap metabolic acidosis that results from insulin deficiency or resistance leading to unrestrained lipolysis and hepatic ketogenesis. The ketone bodies produced, primarily beta-hydroxybutyrate and acetoacetate, are strong acids that consume bicarbonate and produce an elevated anion gap. The typical arterial blood gas demonstrates an elevated anion gap metabolic acidosis with a pH below 7.30, low bicarbonate, and appropriately decreased PaCO2 reflecting respiratory compensation (Kussmaul breathing). The diagnosis requires the triad of hyperglycemia (typically above 250 milligrams per deciliter), ketonemia or ketonuria, and acidosis with an elevated anion gap. Treatment follows a well-established protocol of aggressive intravenous fluid resuscitation to correct dehydration and improve renal perfusion, insulin infusion to suppress ketogenesis and facilitate glucose uptake, potassium replacement (as insulin drives potassium into cells), and close monitoring of glucose, potassium, bicarbonate, and anion gap every one to two hours.

Toxic alcohol ingestions represent a critical subset of anion gap metabolic acidosis that requires rapid recognition because of the potential for severe and irreversible organ damage. Methanol is metabolized by alcohol dehydrogenase to formaldehyde and then to formic acid, which produces retinal toxicity and can cause irreversible blindness, as well as basal ganglia necrosis. Ethylene glycol, found in antifreeze, is metabolized to glycolic acid and then oxalic acid, which precipitates as calcium oxalate crystals in the renal tubules, causing acute kidney injury, and may be identified on urinalysis as envelope-shaped oxalate crystals. Salicylate toxicity produces a characteristic mixed acid-base disturbance, initially with respiratory alkalosis from direct stimulation of the medullary respiratory center, followed by metabolic acidosis from uncoupling of oxidative phosphorylation and accumulation of organic acids. The osmol gap, calculated as the difference between measured and calculated serum osmolality, is an essential diagnostic tool: an osmol gap above 10 milliosmoles per kilogram suggests the presence of an unmeasured osmotically active substance such as a toxic alcohol, although it may normalize as the parent compound is metabolized to its acid metabolites.

<image>Panel A: MUDPILES mnemonic displayed as a vertical list with each letter expanded to its cause: M-Methanol, U-Uremia, D-DKA, P-Propylene glycol, I-Isoniazid/Iron, L-Lactic acidosis, E-Ethylene glycol, S-Salicylates, each with a brief mechanism description and associated clinical scenario. Panel B: Lactic acidosis classification showing Type A (tissue hypoxia from sepsis, shock, severe anemia, CO poisoning) and Type B (no hypoxia, from metformin, malignancy, liver failure, seizures), with a Venn diagram showing sepsis overlapping both types through distributive shock and mitochondrial dysfunction mechanisms. Panel C: DKA pathophysiology flowchart showing insulin deficiency leading to lipolysis, hepatic ketogenesis producing beta-hydroxybutyrate and acetoacetate, resulting in AGMA with the diagnostic triad (hyperglycemia, ketonemia, acidosis), and treatment protocol (fluids, insulin, potassium, monitoring). Panel D: Toxic alcohol panel comparing methanol (formic acid, blindness, basal ganglia), ethylene glycol (oxalic acid, renal failure, oxalate crystals), and salicylates (mixed respiratory alkalosis plus metabolic acidosis), alongside the osmol gap calculation and interpretation (greater than 10 suggests toxic alcohol).</image>

Section 4: Non-Anion Gap Metabolic Acidosis

Non-anion gap metabolic acidosis, also known as hyperchloremic metabolic acidosis, is characterized by a decrease in bicarbonate with a reciprocal increase in chloride, maintaining a normal anion gap. The HARDUPS mnemonic provides a useful framework: Hyperalimentation (total parenteral nutrition with amino acid solutions that generate acid), Acetazolamide (a carbonic anhydrase inhibitor that impairs proximal bicarbonate reabsorption), Renal tubular acidosis (various types with different mechanisms), Diarrhea (loss of bicarbonate-rich intestinal secretions), Ureteral diversion (where urine contacts bowel mucosa that exchanges chloride for bicarbonate), Post-hypocapnia (rapid correction of chronic respiratory alkalosis before renal compensation normalizes), and Saline administration (dilutional acidosis from large-volume normal saline infusion, which has a strong ion difference of zero). Diarrhea and renal tubular acidosis are the most commonly tested and clinically encountered causes.

Renal tubular acidosis encompasses three distinct disorders that impair the kidney's ability to maintain acid-base homeostasis through different tubular mechanisms. Type 1, or distal, renal tubular acidosis results from an inability to secrete hydrogen ions in the collecting duct, leading to an inappropriately alkaline urine pH above 5.5 and hypokalemia from compensatory potassium secretion; causes include autoimmune diseases, amphotericin B, and lithium. Type 2, or proximal, renal tubular acidosis results from impaired bicarbonate reabsorption in the proximal tubule, causing bicarbonate wasting until a new lower steady-state bicarbonate level is reached, at which point the urine pH may fall below 5.5 because the reduced filtered bicarbonate load can be fully reabsorbed by the remaining proximal capacity; this type is associated with Fanconi syndrome (generalized proximal tubular dysfunction with glycosuria, phosphaturia, aminoaciduria, and uricosuria) and causes hypokalemia. Type 4 renal tubular acidosis results from aldosterone deficiency or resistance, leading to impaired sodium reabsorption and potassium and hydrogen ion secretion in the collecting duct, producing hyperkalemia and acidosis with an appropriately acidic urine pH below 5.5; the most common causes are diabetic nephropathy and medications including ACE inhibitors, ARBs, and potassium-sparing diuretics.

Gastrointestinal bicarbonate loss is the most common extrarenal cause of non-anion gap metabolic acidosis. Diarrhea causes direct loss of bicarbonate-rich intestinal secretions, as the lower gastrointestinal tract secretes fluid with a bicarbonate concentration higher than that of plasma. The kidneys respond appropriately by maximizing hydrogen ion secretion and bicarbonate regeneration, producing a concentrated, acidic urine. Pancreatic fistulas and biliary fistulas similarly result in the loss of bicarbonate-rich secretions. Ureteral diversion procedures, in which ureters are anastomosed to a segment of bowel (such as an ileal conduit), allow urine to contact the bowel mucosa, where chloride-bicarbonate exchange results in net bicarbonate loss and chloride absorption, producing a hyperchloremic metabolic acidosis. The degree of acidosis from ureteral diversion is proportional to the duration of urine contact with the bowel mucosa.

The urine anion gap is a simple and clinically useful tool for differentiating renal from extrarenal causes of non-anion gap metabolic acidosis. The urine anion gap is calculated as urine sodium plus urine potassium minus urine chloride. A negative urine anion gap indicates that the kidneys are appropriately excreting ammonium (which is excreted with chloride as ammonium chloride), and therefore the acidosis is due to an extrarenal cause such as diarrhea. A positive urine anion gap indicates that the kidneys are not excreting adequate ammonium, suggesting a renal acidification defect such as renal tubular acidosis. This distinction is clinically important because it directs the diagnostic workup: a negative urine anion gap points toward gastrointestinal or other extrarenal bicarbonate losses, while a positive urine anion gap necessitates further evaluation of renal tubular function, including assessment of urine pH, serum potassium, and specific testing for the type of renal tubular acidosis.

<image>Panel A: HARDUPS mnemonic displayed as a diagnostic reference with each letter expanded: H-Hyperalimentation, A-Acetazolamide, R-RTA, D-Diarrhea, U-Ureteral diversion, P-Post-hypocapnia, S-Saline (dilutional), with clinical context and mechanism for each cause. Panel B: Renal tubular acidosis comparison diagram showing Type 1 (distal, cannot secrete H+, urine pH >5.5, hypokalemia), Type 2 (proximal, cannot reabsorb HCO3, urine pH variable, hypokalemia, Fanconi syndrome), and Type 4 (aldosterone deficiency/resistance, urine pH <5.5, hyperkalemia), with nephron segment affected highlighted for each type. Panel C: GI bicarbonate loss illustration showing intestinal secretions with bicarbonate concentration higher than plasma being lost in diarrhea, appropriate renal compensation with acidic concentrated urine, and ureteral diversion with chloride-bicarbonate exchange across bowel mucosa. Panel D: Urine anion gap diagnostic tool showing the formula (urine Na + K - Cl), with negative result (ammonium excretion present, extrarenal cause such as diarrhea) versus positive result (impaired ammonium excretion, renal cause such as RTA), displayed as a decision fork with clinical implications.</image>

Section 5: Metabolic Alkalosis

Metabolic alkalosis is characterized by an elevated serum bicarbonate and arterial pH above 7.45, and understanding both the generating and maintaining mechanisms is essential for diagnosis and treatment. The causes of metabolic alkalosis are organized by the mechanism of bicarbonate gain or hydrogen ion loss. Gastrointestinal hydrogen ion loss from vomiting and nasogastric suction is one of the most common causes, as the loss of hydrochloric acid from the stomach directly removes hydrogen ions from the body and generates bicarbonate. Renal hydrogen ion loss from diuretic therapy (particularly loop and thiazide diuretics) and hyperaldosteronism generates metabolic alkalosis through enhanced distal nephron hydrogen ion secretion. Contraction alkalosis occurs when extracellular volume loss concentrates the existing bicarbonate stores. Exogenous bicarbonate administration from intravenous sodium bicarbonate, citrate in blood transfusions, or antacid overuse directly adds base to the system.

A clinically useful classification divides metabolic alkalosis into chloride-responsive and chloride-resistant categories based on the urine chloride concentration. Chloride-responsive metabolic alkalosis, characterized by a urine chloride below 20 milliequivalents per liter, includes vomiting, nasogastric suction, remote diuretic use, and contraction alkalosis; these conditions are responsive to saline and chloride repletion because the alkalosis is maintained by volume depletion and chloride deficiency. Chloride-resistant metabolic alkalosis, characterized by a urine chloride above 20 milliequivalents per liter, includes hyperaldosteronism, Cushing syndrome, Bartter syndrome, Gitelman syndrome, and current diuretic use; these conditions do not respond to saline administration because the alkalosis is driven by ongoing mineralocorticoid excess or active renal mechanisms. This classification guides treatment because chloride-responsive alkalosis resolves with volume and chloride repletion, while chloride-resistant alkalosis requires treatment of the underlying cause.

Three factors commonly maintain metabolic alkalosis by preventing the kidney from excreting the excess bicarbonate, and recognizing these maintenance factors is essential for effective treatment. Volume depletion enhances proximal tubular sodium and bicarbonate reabsorption through increased angiotensin II activity and decreased glomerular filtration rate, preventing the kidney from excreting bicarbonate. Chloride depletion limits the availability of chloride for exchange with bicarbonate in the collecting duct, impairing the kidney's ability to excrete bicarbonate. Potassium depletion promotes intracellular hydrogen ion accumulation and enhanced distal tubular hydrogen ion secretion, which regenerates bicarbonate and perpetuates the alkalosis. All three factors often coexist, particularly in vomiting and diuretic use, and correction of all three is necessary for resolution of the alkalosis.

Treatment of metabolic alkalosis is directed at the underlying cause and the maintenance factors. Chloride-responsive metabolic alkalosis is treated with intravenous normal saline to restore volume and provide chloride, combined with potassium chloride supplementation to correct hypokalemia and provide additional chloride; this combination addresses all three maintenance factors (volume, chloride, and potassium depletion). Chloride-resistant metabolic alkalosis requires treatment of the underlying condition: primary hyperaldosteronism requires surgical excision of an aldosterone-producing adenoma or medical therapy with mineralocorticoid receptor antagonists (spironolactone or eplerenone). Acetazolamide, a carbonic anhydrase inhibitor that promotes renal bicarbonate excretion, may be used in patients with metabolic alkalosis who cannot tolerate volume loading, such as those with congestive heart failure. In rare cases of severe, refractory metabolic alkalosis with hemodynamic compromise, dilute hydrochloric acid infusion through a central venous catheter may be necessary.

<image>Panel A: Metabolic alkalosis causes organized by mechanism: GI H+ loss (vomiting, NG suction), renal H+ loss (diuretics, hyperaldosteronism), contraction (volume depletion concentrating HCO3), and exogenous base (IV bicarbonate, citrate from transfusions), with prevalence annotations. Panel B: Chloride-responsive versus chloride-resistant classification showing urine chloride below 20 (responsive: vomiting, remote diuretics, contraction) and above 20 (resistant: hyperaldosteronism, Cushing, current diuretics), with treatment implications for each category. Panel C: Maintenance factors diagram showing three interconnected factors that prevent renal bicarbonate excretion: volume depletion (enhanced proximal reabsorption), chloride depletion (impaired bicarbonate-chloride exchange), and potassium depletion (enhanced distal H+ secretion), all perpetuating the alkalosis. Panel D: Treatment algorithm showing chloride-responsive pathway (IV normal saline plus KCl addressing volume, chloride, and potassium), chloride-resistant pathway (treat underlying cause: surgery for aldosteronoma, spironolactone for hyperaldosteronism), acetazolamide (for volume-overloaded patients), and HCl infusion (severe refractory cases).</image>

Section 6: Respiratory Acidosis

Respiratory acidosis results from alveolar hypoventilation leading to carbon dioxide retention and a decrease in blood pH. The causes are categorized by the level of the respiratory system affected. Central nervous system depression from opioids, benzodiazepines, barbiturates, general anesthesia, and brainstem stroke or hemorrhage reduces the respiratory drive and decreases minute ventilation. Neuromuscular disorders including myasthenia gravis, Guillain-Barre syndrome, amyotrophic lateral sclerosis, muscular dystrophies, and phrenic nerve injury impair the ability of respiratory muscles to generate adequate tidal volumes. Chest wall abnormalities including severe kyphoscoliosis, obesity hypoventilation syndrome, and flail chest mechanically restrict thoracic expansion. Airway and pulmonary diseases including severe chronic obstructive pulmonary disease, severe asthma exacerbation, upper airway obstruction, and severe pneumonia increase the work of breathing and impair carbon dioxide elimination through ventilation-perfusion mismatch and alveolar hypoventilation.

The distinction between acute and chronic respiratory acidosis is clinically critical because it determines the expected degree of metabolic compensation and guides management decisions. In acute respiratory acidosis, developing over minutes to hours, the kidneys have not yet had time to mount a significant compensatory response, and the bicarbonate increases by only 1 milliequivalent per liter for every 10 millimeters of mercury increase in PaCO2, reflecting only the immediate buffering by hemoglobin and tissue buffers. In chronic respiratory acidosis, developing over days to weeks, the kidneys increase bicarbonate reabsorption and generation, producing a much more robust compensation of 3.5 milliequivalents per liter increase in bicarbonate for every 10 millimeters of mercury increase in PaCO2. This distinction is critical for interpretation of the blood gas: a patient with a PaCO2 of 60 millimeters of mercury and a bicarbonate of 26 has an acute process (minimal compensation), while the same PaCO2 with a bicarbonate of 31 suggests a chronic process with appropriate renal compensation.

The clinical manifestations of respiratory acidosis are primarily neurological and cardiovascular, reflecting the effects of hypercapnia and acidosis on the central nervous system and cardiovascular system. Mild hypercapnia produces headache, anxiety, and restlessness. Moderate hypercapnia causes confusion, somnolence, and asterixis (flapping tremor). Severe hypercapnia produces obtundation, coma, and papilledema from increased intracranial pressure due to cerebral vasodilation. Concurrent hypoxemia, which frequently accompanies respiratory acidosis, amplifies the neurological effects and may cause cyanosis, cardiac arrhythmias, and cardiovascular instability. The clinical severity depends not only on the absolute PaCO2 level but also on the rate of rise, as the brain adapts more effectively to chronic hypercapnia than to acute elevations.

Treatment of respiratory acidosis is directed at the underlying cause and at improving alveolar ventilation. The primary goal is always to treat the underlying condition: for opioid overdose, naloxone administration reverses respiratory depression; for myasthenic crisis, plasmapheresis or intravenous immunoglobulin addresses the neuromuscular junction dysfunction. Ventilatory support is indicated when the underlying cause cannot be rapidly reversed or when the degree of hypoventilation threatens life. Bilevel positive airway pressure, commonly known as BiPAP, is the first-line ventilatory intervention for acute exacerbations of chronic obstructive pulmonary disease with respiratory acidosis, as it augments tidal volume and reduces the work of breathing without the risks of invasive ventilation. Endotracheal intubation with mechanical ventilation is reserved for patients who fail non-invasive ventilation, who cannot protect their airway, or who have severe respiratory failure. A critical caution in the management of chronic respiratory acidosis is to avoid rapid correction of the PaCO2, as the elevated bicarbonate from chronic renal compensation will produce a post-hypercapnic metabolic alkalosis if the carbon dioxide is lowered too quickly, potentially causing alkalemia, seizures, and cardiac arrhythmias.

<image>Panel A: Respiratory acidosis causes organized by anatomical level: CNS depression (opioids, sedatives, stroke with brain diagram), neuromuscular (myasthenia gravis, GBS, ALS with nerve-muscle junction), chest wall (kyphoscoliosis, obesity hypoventilation with thoracic diagram), and airway/pulmonary (COPD, asthma, obstruction with lung diagram). Panel B: Acute versus chronic respiratory acidosis comparison showing expected compensation: acute (HCO3 rises 1 per 10 CO2 increase, minimal buffering) versus chronic (HCO3 rises 3.5 per 10 CO2 increase, full renal compensation), with example ABG values demonstrating the same PaCO2 of 60 with different bicarbonate levels. Panel C: Clinical manifestation progression showing neurological effects of increasing hypercapnia: mild (headache, anxiety), moderate (confusion, somnolence, asterixis), and severe (coma, papilledema from cerebral vasodilation and increased ICP), with concurrent hypoxemia amplifying all effects. Panel D: Treatment approach showing underlying cause treatment (naloxone for opioid, plasmapheresis for myasthenia), non-invasive ventilation (BiPAP for COPD exacerbation with settings), invasive ventilation (intubation for failure or airway compromise), and caution about post-hypercapnic alkalosis from rapid correction of chronic respiratory acidosis.</image>

Section 7: Respiratory Alkalosis

Respiratory alkalosis results from alveolar hyperventilation that produces excessive carbon dioxide elimination and an increase in blood pH above 7.45. The causes of respiratory alkalosis are diverse and include hypoxia-driven hyperventilation from pneumonia, pulmonary embolism, high altitude, and any condition causing hypoxemia, where peripheral and central chemoreceptors stimulate increased ventilation in response to low arterial oxygen tension. Central nervous system stimulation of the respiratory center occurs with anxiety and panic attacks, pain, stroke, brain injury, meningitis, and encephalitis. Pulmonary causes include pulmonary embolism (which stimulates hyperventilation both through hypoxemia and through stimulation of juxta-capillary J receptors in the lung), early asthma (before airway obstruction produces CO2 retention), and interstitial lung disease. Pharmacological causes include salicylate toxicity (which directly stimulates the medullary respiratory center) and progesterone (which explains the mild chronic respiratory alkalosis of pregnancy). Other causes include sepsis (early hyperventilation is common), liver failure (due to circulating toxins that stimulate the respiratory center), and pregnancy (progesterone-mediated chronic respiratory alkalosis with PaCO2 typically around 30 millimeters of mercury).

The distinction between acute and chronic respiratory alkalosis follows the same principle as respiratory acidosis but with different compensation magnitudes. In acute respiratory alkalosis, the bicarbonate decreases by 2 milliequivalents per liter for every 10 millimeters of mercury decrease in PaCO2, reflecting immediate buffering. In chronic respiratory alkalosis, the kidneys reduce bicarbonate reabsorption and generation, producing a more substantial compensation of 5 milliequivalents per liter decrease in bicarbonate for every 10 millimeters of mercury decrease in PaCO2. Chronic respiratory alkalosis is notable because it is the only acid-base disorder in which compensation can return the pH to the normal range or even slightly below, which can complicate interpretation if the clinician is not aware of this exception.

The clinical manifestations of respiratory alkalosis result from both the direct effects of hypocapnia and the indirect effects of alkalemia on ionized calcium and cerebral blood flow. Light-headedness, dizziness, and a sensation of breathlessness are common symptoms and result from cerebral vasoconstriction caused by hypocapnia, which reduces cerebral blood flow. Perioral and extremity paresthesias and, in severe cases, carpopedal spasm and tetany result from decreased ionized calcium; alkalemia increases the proportion of calcium bound to albumin, reducing the physiologically active ionized fraction and producing functional hypocalcemia. Chest pain and palpitations may mimic cardiac disease and are particularly common in anxiety-related hyperventilation. Severe respiratory alkalosis can cause confusion, syncope, and seizures from the combined effects of cerebral hypoperfusion and functional hypocalcemia.

Treatment of respiratory alkalosis is directed at the underlying cause rather than at the alkalosis itself. For anxiety-related hyperventilation, reassurance, relaxation techniques, and anxiolytics are the mainstays of therapy; the historical practice of rebreathing into a paper bag is no longer recommended because it may worsen hypoxemia in patients whose hyperventilation is driven by unrecognized hypoxia rather than anxiety. For hypoxia-driven hyperventilation, supplemental oxygen and treatment of the underlying cause (antibiotics for pneumonia, anticoagulation for pulmonary embolism) are appropriate. For patients on mechanical ventilation with iatrogenic respiratory alkalosis, the minute ventilation should be reduced by decreasing the respiratory rate or tidal volume. For salicylate-induced respiratory alkalosis, activated charcoal for gastrointestinal decontamination, urinary alkalinization with sodium bicarbonate to enhance salicylate excretion, and hemodialysis for severe toxicity are indicated. In most cases, the respiratory alkalosis resolves when the underlying cause is treated, and specific intervention to raise the PaCO2 is not necessary.

<image>Panel A: Respiratory alkalosis causes organized by mechanism: hypoxia-driven (pneumonia, PE, high altitude with pulse oximetry), CNS stimulation (anxiety, pain, stroke, meningitis with brain diagram), pulmonary (PE with J-receptor stimulation, early asthma, ILD), pharmacological (salicylates with direct medullary stimulation, progesterone in pregnancy), and other (sepsis, liver failure). Panel B: Acute versus chronic respiratory alkalosis compensation showing acute (HCO3 decreases 2 per 10 CO2 decrease) and chronic (HCO3 decreases 5 per 10 CO2 decrease), with the unique note that chronic respiratory alkalosis is the only disorder where compensation can fully normalize or even overcorrect the pH. Panel C: Clinical manifestation diagram showing cerebral vasoconstriction from hypocapnia (light-headedness, dizziness, syncope), functional hypocalcemia from alkalemia (paresthesias, carpopedal spasm, tetany), and cardiac symptoms (chest pain, palpitations mimicking cardiac disease), with mechanism arrows. Panel D: Treatment by cause showing anxiety (reassurance, anxiolytics, no paper bag rebreathing), hypoxia (supplemental O2, treat underlying cause), mechanical ventilation (reduce rate or tidal volume), and salicylate toxicity (charcoal, urinary alkalinization, hemodialysis), with the principle that treating the cause resolves the alkalosis.</image>

Section 8: Mixed Disorders

Mixed acid-base disorders occur when two or more primary acid-base disturbances are present simultaneously in the same patient, and their recognition requires systematic analysis and clinical correlation. The key clues to recognizing a mixed disorder include compensation that is more or less than expected for the primary disorder (using the compensation formulas), a normal pH in the presence of significantly abnormal PaCO2 and bicarbonate values (suggesting two opposing processes), and a delta-delta ratio outside the expected range of 1 to 2 for a pure anion gap metabolic acidosis. Clinical context is essential because certain clinical scenarios are characteristically associated with specific mixed disorders, and the astute clinician can anticipate and recognize these patterns.

The delta-delta ratio is the most powerful analytical tool for identifying mixed disorders in the setting of an anion gap metabolic acidosis. The ratio is calculated as the change in anion gap (current AG minus normal AG of 12) divided by the change in bicarbonate (normal HCO3 of 24 minus current HCO3). A ratio less than 1 indicates that the bicarbonate has decreased more than can be accounted for by the increase in unmeasured anions alone, revealing a concurrent non-anion gap metabolic acidosis that is producing additional bicarbonate loss through a separate mechanism (such as diarrhea superimposed on diabetic ketoacidosis). A ratio between 1 and 2 indicates a pure anion gap metabolic acidosis, where the bicarbonate decrease is proportional to the anion gap increase. A ratio greater than 2 indicates that the bicarbonate has not decreased as much as expected given the increase in unmeasured anions, revealing a concurrent metabolic alkalosis that is partially offsetting the acid load (such as vomiting superimposed on diabetic ketoacidosis).

Common mixed acid-base disorders are encountered regularly in clinical practice and have characteristic presentations. The combination of metabolic acidosis plus respiratory acidosis occurs in cardiac arrest and severe pneumonia with sepsis, where tissue hypoperfusion produces lactic acidosis while respiratory failure causes CO2 retention. Metabolic acidosis plus respiratory alkalosis occurs in sepsis (lactic acidosis with hyperventilation) and salicylate toxicity (which directly stimulates the respiratory center while producing metabolic acid). Metabolic acidosis combined with metabolic alkalosis occurs when a patient with diabetic ketoacidosis is also vomiting, or when a patient with lactic acidosis from sepsis has concurrent metabolic alkalosis from nasogastric suctioning. Respiratory acidosis combined with metabolic alkalosis is a common pattern in patients with chronic obstructive pulmonary disease who are taking diuretics, where chronic CO2 retention coexists with diuretic-induced alkalosis.

Triple acid-base disorders involve three simultaneous primary disturbances and represent the most complex analytical challenge. A common scenario is a critically ill patient in the intensive care unit with an anion gap metabolic acidosis (from sepsis or renal failure), a concurrent non-anion gap metabolic acidosis (from large-volume normal saline resuscitation), and a metabolic alkalosis (from nasogastric suctioning or vomiting). The approach to triple disorders requires the same systematic analysis: identify the primary disorder from the pH, assess the anion gap, apply the delta-delta ratio to detect additional metabolic processes, and verify that the respiratory compensation is appropriate for the net metabolic disturbance. Clinical context is invaluable because it identifies which processes are likely present and guides the interpretation of ambiguous laboratory values. The treatment of mixed and triple disorders must address each individual component.

<image>Panel A: Mixed disorder recognition clues displayed as a checklist: compensation outside expected range (formulas reference), normal pH with abnormal PaCO2 and HCO3 (suggesting opposing processes), delta-delta ratio outside 1-2 range (additional metabolic process), and clinical context providing pre-test probability, with examples for each clue. Panel B: Delta-delta ratio interpretation displayed as a horizontal number line with three zones: less than 1 (concurrent AGMA plus NAGMA, example: DKA plus diarrhea), 1-2 (pure AGMA), and greater than 2 (AGMA plus metabolic alkalosis, example: DKA plus vomiting), with calculation formula and clinical examples at each zone. Panel C: Common mixed disorder pairs shown as four clinical vignettes: metabolic acidosis plus respiratory acidosis (cardiac arrest), metabolic acidosis plus respiratory alkalosis (sepsis, salicylate), metabolic acidosis plus metabolic alkalosis (DKA with vomiting), and respiratory acidosis plus metabolic alkalosis (COPD on diuretics), each with characteristic ABG patterns. Panel D: Triple disorder analysis framework showing a complex ICU patient with simultaneous AGMA (sepsis), NAGMA (saline resuscitation), and metabolic alkalosis (NG suction), with step-by-step analytical approach: identify primary disorder, calculate AG, apply delta-delta, verify respiratory compensation, and integrate clinical context.</image>

Section 9: Clinical Scenarios

Diabetic ketoacidosis presents a characteristic arterial blood gas pattern that serves as an excellent example of systematic interpretation. The pH is low, typically below 7.30, indicating acidemia. The PaCO2 is low, reflecting appropriate respiratory compensation through Kussmaul breathing (deep, rapid respirations). The bicarbonate is low, confirming metabolic acidosis as the primary disorder. The anion gap is elevated due to the accumulation of ketone bodies (beta-hydroxybutyrate and acetoacetate). Application of Winter's formula confirms appropriate respiratory compensation, and the delta-delta ratio should fall between 1 and 2 for a pure ketoacidosis. However, if the patient has been vomiting (common in DKA), the delta-delta ratio may exceed 2, indicating a concurrent metabolic alkalosis. Management includes aggressive fluid resuscitation, insulin infusion, potassium monitoring and replacement, and serial blood gas and electrolyte monitoring until the anion gap normalizes and the acidosis resolves.

Salicylate toxicity produces a distinctive mixed acid-base pattern that is nearly pathognomonic. In the early phase, respiratory alkalosis predominates as salicylates directly stimulate the medullary respiratory center, causing hyperventilation and a low PaCO2 with elevated pH. As toxicity progresses, a metabolic acidosis develops from the uncoupling of oxidative phosphorylation, accumulation of organic acids, and salicylate-mediated interference with the Krebs cycle, producing an elevated anion gap. The classic mixed pattern shows a low PaCO2 (respiratory alkalosis) with a low bicarbonate (metabolic acidosis), and the pH may be normal, high, or low depending on the relative magnitudes of the two processes. Treatment includes gastrointestinal decontamination with activated charcoal, urinary alkalinization with sodium bicarbonate infusion to enhance renal salicylate excretion by ion trapping, and hemodialysis for severe toxicity with levels above 100 milligrams per deciliter, altered mental status, or renal failure.

Acute exacerbation of chronic obstructive pulmonary disease produces an acid-base pattern that requires careful distinction between the acute and chronic components. The baseline chronic respiratory acidosis is characterized by an elevated PaCO2 with an appropriately elevated bicarbonate reflecting chronic renal compensation. During an acute exacerbation, the PaCO2 rises further, but the bicarbonate is higher than expected for a purely acute process, indicating the underlying chronic component. The pH may be near normal if the acute exacerbation is mild, or frankly acidemic if the acute CO2 rise is significant. This pattern of "acute on chronic" respiratory acidosis is recognized by a bicarbonate that is higher than predicted by the acute compensation formula but consistent with the chronic compensation formula plus the acute change. Treatment includes inhaled bronchodilators, systemic corticosteroids, antibiotics if an infectious trigger is identified, and bilevel positive airway pressure for moderate to severe cases.

Vomiting with dehydration produces a predictable acid-base pattern that illustrates the integration of metabolic alkalosis with appropriate respiratory compensation. The primary disorder is metabolic alkalosis from gastric hydrochloric acid loss, producing an elevated bicarbonate and elevated pH. Respiratory compensation involves mild hypoventilation to raise PaCO2 and partially offset the alkalemia, although respiratory compensation for metabolic alkalosis is inherently limited because hypoxemia from hypoventilation limits the degree of CO2 retention. Associated laboratory findings include hypochloremia (from chloride loss in gastric secretions), hypokalemia (from renal potassium wasting driven by alkalosis and volume depletion), and prerenal azotemia (from dehydration). Treatment with intravenous normal saline addresses the volume depletion and provides chloride, while potassium chloride supplementation corrects hypokalemia and provides additional chloride, together reversing the maintenance factors and allowing the kidney to excrete the excess bicarbonate.

<image>Panel A: DKA blood gas interpretation showing a sample ABG with annotations: low pH (acidemia), low PaCO2 (respiratory compensation via Kussmaul breathing), low HCO3 (metabolic acidosis), elevated anion gap (ketones), Winter's formula verification, and delta-delta ratio check, alongside the DKA treatment protocol (fluids, insulin, potassium, monitoring). Panel B: Salicylate toxicity mixed acid-base pattern showing the biphasic progression from early respiratory alkalosis (direct medullary stimulation) to mixed respiratory alkalosis plus metabolic acidosis (AGMA from uncoupled oxidative phosphorylation), with treatment steps (charcoal, urinary alkalinization, hemodialysis). Panel C: COPD acute-on-chronic pattern showing baseline chronic respiratory acidosis (elevated CO2 with compensated HCO3) progressing to acute exacerbation (further CO2 rise with HCO3 higher than acute prediction), with comparison of expected acute versus chronic compensation and treatment (bronchodilators, steroids, BiPAP). Panel D: Vomiting with dehydration pattern showing metabolic alkalosis (elevated HCO3 and pH), mild respiratory compensation (slightly elevated CO2), and associated findings (low Cl, low K, prerenal azotemia), with treatment (IV normal saline, KCl supplementation) addressing all maintenance factors.</image>

Section 10: Quick Reference

The expected compensation formulas are essential tools that must be memorized for rapid bedside application. For metabolic acidosis, Winter's formula states that the expected PaCO2 equals 1.5 times the bicarbonate plus 8, with a range of plus or minus 2, and this formula is the most frequently tested and clinically applied compensation calculation. For metabolic alkalosis, the expected PaCO2 equals 0.7 times the bicarbonate plus 21, with a range of plus or minus 2. For acute respiratory acidosis, the bicarbonate rises by 1 milliequivalent per liter for every 10 millimeters of mercury rise in PaCO2 above 40. For chronic respiratory acidosis, the bicarbonate rises by 3.5 milliequivalents per liter for every 10 millimeters of mercury rise. For acute respiratory alkalosis, the bicarbonate falls by 2 milliequivalents per liter for every 10 millimeters of mercury fall in PaCO2 below 40. For chronic respiratory alkalosis, the bicarbonate falls by 5 milliequivalents per liter for every 10 millimeters of mercury fall.

The anion gap analysis provides critical diagnostic information in metabolic acidosis. The standard anion gap formula is sodium minus the sum of chloride and bicarbonate, with a normal value of 8 to 12 milliequivalents per liter, though this varies by laboratory methodology. The corrected anion gap accounts for hypoalbuminemia, which is common in hospitalized patients and reduces the baseline unmeasured anion pool: the corrected gap equals the calculated gap plus 2.5 times the quantity of 4 minus the measured albumin in grams per deciliter. This correction prevents underestimation of the true anion gap in hypoalbuminemic patients, which could cause a clinically significant anion gap metabolic acidosis to be missed. The delta ratio (delta-delta) is calculated as the change in anion gap from normal divided by the change in bicarbonate from normal and serves as the definitive tool for identifying additional metabolic processes in the presence of an anion gap metabolic acidosis.

Several key numerical values serve as essential reference points for acid-base interpretation. The normal arterial pH is 7.40, representing the precise midpoint of the normal range and the value toward which all physiological compensation is directed. The normal PaCO2 is 40 millimeters of mercury, the normal bicarbonate is 24 milliequivalents per liter, and together these values satisfy the Henderson-Hasselbalch equation at a pH of 7.40. The normal anion gap is 10 to 12 milliequivalents per liter, and values above 14 should be considered elevated. These anchor values should be committed to memory, as they serve as the baseline from which all calculations and interpretations are performed.

The osmol gap is an important calculation in the evaluation of anion gap metabolic acidosis when toxic alcohol ingestion is suspected. The calculated osmolality is estimated as 2 times the serum sodium plus glucose divided by 18 plus blood urea nitrogen divided by 2.8, and this value is then compared to the measured serum osmolality from the laboratory. The osmol gap is the difference between the measured and calculated osmolality, and a normal osmol gap is less than 10 milliosmoles per kilogram. An elevated osmol gap above 10 suggests the presence of an osmotically active substance not accounted for in the calculation, such as methanol, ethylene glycol, isopropanol, or ethanol. However, the osmol gap has important limitations: it may normalize as the parent alcohol is metabolized to its acid metabolite (which is not osmotically active but does produce an anion gap), creating a temporal evolution from a high osmol gap with a normal anion gap in early poisoning to a high anion gap with a normal osmol gap in late poisoning. Therefore, both the anion gap and osmol gap should be evaluated together in suspected toxic alcohol ingestions.

<image>Panel A: Compensation formulas reference card displaying all six formulas in a clean, memorization-friendly format: Winter's formula (metabolic acidosis), metabolic alkalosis formula, and acute and chronic formulas for both respiratory acidosis and alkalosis, with practice examples for each formula. Panel B: Anion gap analysis reference showing the standard formula (Na minus Cl minus HCO3, normal 8-12), albumin-corrected formula (AG plus 2.5 times [4 minus albumin]), and delta ratio calculation (change in AG divided by change in HCO3) with interpretation ranges, presented as a step-by-step calculation guide. Panel C: Key numerical values displayed as a quick-reference card: normal pH 7.40, normal PaCO2 40 mmHg, normal HCO3 24 mEq/L, normal AG 10-12 mEq/L, with the Henderson-Hasselbalch equation showing how these values are interrelated. Panel D: Osmol gap calculation showing the formula for calculated osmolality (2Na + glucose/18 + BUN/2.8), normal osmol gap less than 10, causes of elevated gap (methanol, ethylene glycol, isopropanol, ethanol), and the temporal evolution from high osmol gap to high anion gap as toxic alcohol is metabolized.</image>

Summary

• ABG interpretation follows a systematic four-step approach: pH (acidemia vs alkalemia), primary disorder (metabolic vs respiratory), compensation adequacy, and anion gap calculation
• Anion gap metabolic acidosis (MUDPILES): lactic acidosis is the most common; DKA produces elevated ketones; toxic alcohols require osmol gap evaluation
• Non-anion gap metabolic acidosis: diarrhea is the most common GI cause; RTA types differ by potassium level and urine pH; urine anion gap differentiates renal from extrarenal causes
• Metabolic alkalosis: classify as chloride-responsive (vomiting, diuretics; treat with saline and KCl) versus chloride-resistant (hyperaldosteronism; treat the underlying cause)
• Respiratory acidosis: alveolar hypoventilation; distinguish acute from chronic by compensation; BiPAP for COPD exacerbation
• Respiratory alkalosis: hyperventilation from many causes including anxiety, hypoxia, and sepsis; treat the underlying cause
• Mixed disorders: suspect when compensation is "off" or delta-delta ratio is outside 1-2 range
• Delta-delta ratio less than 1 indicates concurrent NAGMA; ratio greater than 2 indicates concurrent metabolic alkalosis
• Treatment always addresses the underlying cause rather than correcting the numbers alone
• Common clinical patterns: DKA (AGMA), salicylate (mixed respiratory alkalosis plus metabolic acidosis), COPD (chronic respiratory acidosis)

Key Terms

This content is subject to the MIT License. © 2024–2026 Hibbert School of Medicine.

Read this lecture as Markdown